skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The Crystal Structure of CD8alpha,Beta in Complex With YTS156.7.7 Fab And Interaction With Other CD8 Antibodies Define the Binding Mode of CD8alpha,Beta to MHC Class I

Journal Article · · J. Mol. Biol. 384:1190-1202,2008
OSTI ID:953561

The CD8{alpha}{beta} heterodimer interacts with class I pMHC on antigen-presenting cells as a co-receptor for TCR-mediated activation of cytotoxic T cells. To characterize this immunologically important interaction, we used monoclonal antibodies (mAbs) specific to either CD8{alpha} or CD8{beta} to probe the mechanism of CD8{alpha}{beta} binding to pMHCI. The YTS156.7 mAb inhibits this interaction and blocks T cell activation. To elucidate the molecular basis for this inhibition, the crystal structure of the CD8{alpha}{beta} immunoglobulin-like ectodomains were determined in complex with mAb YTS156.7 Fab at 2.7 {angstrom} resolution. The YTS156.7 epitope on CD8{beta} was identified and implies that residues in the CDR1 and CDR2-equivalent loops of CD8{beta} are occluded upon binding to class I pMHC. To further characterize the pMHCI/CD8{alpha}{beta} interaction, binding of class I tetramers to CD8{alpha}{beta} on the surface of T cells was assessed in the presence of anti-CD8 mAbs. In contrast to YTS156.7, mAb YTS105.18, which is specific for CD8{alpha}, does not inhibit binding of CD8{alpha}{beta} to class I tetramers, indicating the YTS105.18 epitope is not occluded in the pMHCI/CD8{alpha}{beta} complex. Together, these data indicate a model for the pMHCI/CD8{alpha}{beta} interaction similar to that observed for CD8{alpha}{alpha} in the CD8{alpha}{alpha}/pMHCI complex, but in which CD8{alpha} occupies the lower orientation (membrane proximal to the antigen presenting cell), and CD8{beta} occupies the upper position (membrane distal). The implication of this molecular assembly for the function of CD8{alpha}{beta} in T cell activation is discussed.

Research Organization:
SLAC National Accelerator Lab., Menlo Park, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-76SF00515
OSTI ID:
953561
Report Number(s):
SLAC-REPRINT-2009-322; JMOBAK; TRN: US201002%%1389
Journal Information:
J. Mol. Biol. 384:1190-1202,2008, Vol. 384, Issue 5; ISSN 0022-2836
Country of Publication:
United States
Language:
English